cropped-cropped-favicon.png
https://www.recce.com.au/recce_dev/wp-content/uploads/2023/09/cropped-cropped-favicon.png
Menu
https://www.recce.com.au/recce_dev/wp-content/uploads/2023/09/cropped-cropped-favicon.png
Recce Pharmaceuticals Ltd (ASX:RCE, FSE: R9Q) is developing a New Class of Synthetic Anti-Infectives designed to address the urgent global health threat of antibiotic-resistant superbugs.
© 2024 Recce Pharmaceuticals